By Shania Kennedy
February 27, 2023 – Hackensack Meridian Health and medical technology company Neosoma, Inc. launched a partnership to use artificial intelligence (AI) to advance brain cancer research and treatment.
According to the press…
There may be additional delays in the Department of Veterans Affairs (VA) Oracle Cerner EHR rollout due to concerns over how the health IT interacts with medical research systems, according to reporting from FedScoop….
Continue Reading
If you work in healthcare IT, you must have heard the name Epic. Epic is a renowned EHR provider, that covers around a third of the US healthcare market. In 2019, Epic launched Cosmos, a…
Continue Reading
Top News
Teladoc Health reports Q4 results: revenue up 15%, EPS –$0.23 versus –$0.07, beating revenue expectations but falling short on earnings.
The company reported a staggering $13.7 billion loss for FY 2022, much of…
VisualDx this week announced that the American Medical Women’s Academy, which is dedicated to advancing women in medicine and improving women’s health, will be able to use its platform for AI-enabled clinical research and…
Continue Reading
Hospitals and health systems traditionally have experienced significant challenges in finding insights from data at scale because their data universes are so complicated. A standard health system has a huge volume of data from…
Continue Reading
Andrew Barnhill, Head of Public Policy, Global Legal, IQVIAAlexandra Weiss, Director of Strategic Partnerships, Patient Advocacy Organizations, IQVIADiversity is paramount to the success of clinical research, both ethically and scientifically. Without adequate representation of…
Continue Reading
In June, the United States Supreme Court abandoned nearly 50 years of precedent and, for the first time in this nation’s history, eliminated a fundamental right: the right to choose. This decision, Dobbs v….
Continue Reading
Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…
Continue Reading
February 14, 2023 – Health IT vendor Veradigm, formerly Allscripts, announced a collaboration with healthcare data ecosystem HealthVerity that will leverage registry data to advance chronic disease research. The partnership will bridge Veradigm’s cardiology and metabolic registries with consumer data collected by HealthVerity, offering clinical researchers access to research-ready data. The Veradigm Cardiology Registry boasts over 102 million patient records representing more than 19.9 million unique patients, making it one of the largest outpatient cardiovascular quality improvement registries. The registry follows cardiac patients over time, monitoring essential measures such as demographics, plan of care, cardiac events and comorbidities, exams, procedures, lab…
Continue Reading
